C. Gillett et al., AMPLIFICATION AND OVEREXPRESSION OF CYCLIN-D1 IN BREAST-CANCER DETECTED BY IMMUNOHISTOCHEMICAL STAINING, Cancer research, 54(7), 1994, pp. 1812-1817
Immunohistochemical staining with a monoclonal antibody against human
cyclin D1 can be used to identify breast cancers that have an amplific
ation of the q13 region of chromosome II. In general, the intensity of
staining is directly proportional to the degree of DNA amplification.
In two unusual tumors, in which the CCND1 locus is highly amplified b
ut staining is relatively weak, it appears that the DNA has undergone
rearrangement and that the amplified/rearranged CCND1 allele may have
reduced transcriptional activity. More significantly, the immunohistoc
hemical technique identifies additional tumors in which the cyclin D1
gene is overexpressed with only marginal or undetectable increases in
copy number, implying that other mechanisms can lead to deregulated ex
pression. These results suggest that the frequency of overexpression i
s much higher than previously concluded from DNA-based analyses and th
at more than one-third of human breast cancers may contain excessive l
evels of cyclin D1. The technique we describe should facilitate the de
tection of this abnormality in a clinical setting and clarify its prog
nostic significance.